I might have avoided ovarian cancer if I lived in England not Wales

I Might Have Avoided Ovarian Cancer if I Lived in England, Not Wales

A Genetic Oversight Across Borders

I might have avoided ovarian cancer - Heather Morgan, now 59, believes her ovarian cancer diagnosis could have been prevented if she had been living in England rather than Wales at the time of her 2014 breast cancer diagnosis. Her location in Monmouthshire, just eight miles west of the English border, meant she wasn’t offered the same genetic screening opportunity as patients in England. In the UK, individuals with triple negative breast cancer under 50 are automatically referred for genetic testing, a protocol that was not yet in place for Welsh residents.

"I am mad annoyed," Heather said. "It's changed everything," she added, noting that her 10-year survival rate for ovarian cancer is 35%. "If I had been tested back then, we would have known I was at high risk for ovarian cancer. I would have had my ovaries removed immediately. It would have been a no-brainer."

Delayed Detection and Genetic Mutations

It wasn’t until 2021 that a noticeable lump in Heather’s abdomen led to further tests, confirming her BRCA1 gene mutation. This genetic alteration significantly raises the likelihood of developing both breast and ovarian cancer. For instance, the NHS reports that women in the UK have a 12.5% lifetime risk of breast cancer and 2% chance of ovarian cancer, but these figures jump to 72% and 44% respectively for BRCA1 carriers. Heather’s case highlights how genetic testing can be a life-saving tool when available.

By 2015, Wales had updated its guidelines to match England’s, yet Heather had already completed her treatment and wasn’t invited for the test. "If I’m going to the supermarket and I’ve gone a bit over budget, I’ll think, why save money? What’s the point, you’ll be dead next week, just buy it," she remarked, illustrating the impact of delayed diagnosis on her quality of life.

Advocacy and Health Disparities

Heather now supports the National Hereditary Breast Cancer Helpline, which provides guidance for people with inherited cancer risks. The charity recently opened its first information center in Flint, north Wales, and is expanding to address cancers linked to BRCA mutations. Founder Wendy Watson emphasized that healthcare disparities extend beyond England and Wales, often occurring within regions themselves. "We do have postcode lottery healthcare," Watson noted. "We shouldn’t have, but at least we’re here to provide people with access to the information."

Heather’s family also experienced variations in care. While her younger daughter in the northeast of England was invited for genetic testing, her older daughter in the northwest was not. This inconsistency underscores the need for standardized protocols, even within the UK. NICE guidelines recommend annual MRIs for BRCA carriers aged 30-49, and mammograms from 40 onwards, yet implementation remains uneven.